LIST OF BINDING INTERFACES for query 'PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1' in category 'PROTEIN NAME'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)

PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details
2gqg	1N1	Dasatinib (DB01254)	Dasatinib is a tyrosine kinase inhibitor used for the treatment of lymphoblastic or chronic myeloid leukemia with resistance or intolerance to prior therapy.	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1 (Homo sapiens)	PK_Tyr_Ser-Thr	2GQG_A_1N1A501	Details
3ik3	0LI	Ponatinib (DB08901)	Ponatinib is a kinase inhibitor used to treat patients with various types of chronic myeloid leukemia (CML).	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1 (Mus musculus)	PK_Tyr_Ser-Thr	3IK3_A_0LIA1	Details
PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details

[["2gqg","1N1","Dasatinib (DB01254)","Homo sapiens","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","PK_Tyr_Ser-Thr"],["3ik3","0LI","Ponatinib (DB08901)","Mus musculus","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","PK_Tyr_Ser-Thr"]]